Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Thomas, Douglas D. / Turk, Boris / Wittinghofer, Alfred


IMPACT FACTOR 2018: 3.014
5-year IMPACT FACTOR: 3.162

CiteScore 2018: 3.09

SCImago Journal Rank (SJR) 2018: 1.482
Source Normalized Impact per Paper (SNIP) 2018: 0.820

Online
ISSN
1437-4315
See all formats and pricing
More options …
Volume 383, Issue 1

Issues

Osteopontin Modulates Prostate Carcinoma Invasive Capacity through RGD-Dependent Upregulation of Plasminogen Activators

Adriano Angelucci / Claudio Festuccia / Gabriele DAndrea / Anna Teti / Mauro Bologna
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/BC.2002.024

Abstract

Osteopontin, a noncollageneous bone matrix protein, is produced in several human tumors but its role in cancer progression has been only partially elucidated. In this study we investigated the potential role of osteopontin in the malignancy of prostate cancer cells. Chemotaxis and chemoinvasion analyses revealed a dosedependent increase in PC3 cell movement induced by osteopontin and a strict dependence of cell invasion on αvβ3 integrin function. The pattern of protease expression was modified by osteopontin and was characterized by an upregulation of plasminogen activators. Our findings suggest that osteopontin may confer selective malignant potential to prostate cancer cells through the enhancement of their invasive and proteolytic capability.

About the article

Published Online: 2005-06-01

Published in Print: 2002-01-23


Citation Information: Biological Chemistry, Volume 383, Issue 1, Pages 229–234, ISSN (Print) 1431-6730, DOI: https://doi.org/10.1515/BC.2002.024.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Supaporn Khamchun, Kanyarat Sueksakit, Sakdithep Chaiyarit, and Visith Thongboonkerd
JBIC Journal of Biological Inorganic Chemistry, 2019, Volume 24, Number 2, Page 235
[2]
Guo-Xin Zhang, Zhi-Quan Zhao, Hong-Di Wang, and Bo Hao
World Journal of Gastroenterology, 2004, Volume 10, Number 2, Page 205
[3]
Theodora Stivarou and Evangelia Patsavoudi
Cancers, 2015, Volume 7, Number 1, Page 238
[4]
Nadia Rucci and Adriano Angelucci
BioMed Research International, 2014, Volume 2014, Page 1
[5]
Mark Sutherland, Andrew Gordon, Steven Shnyder, Laurence Patterson, and Helen Sheldrake
Cancers, 2012, Volume 4, Number 4, Page 1106
[6]
Tapan Bhavsar, Peter McCue, and Ruth Birbe
Seminars in Oncology, 2013, Volume 40, Number 3, Page 259
[8]
T.M. Tilli, L.C. Thuler, A.R. Matos, C.M. Coutinho-Camillo, F.A. Soares, E.A. da Silva, A.F. Neves, L.R. Goulart, and E.R. Gimba
Experimental and Molecular Pathology, 2012, Volume 92, Number 1, Page 13
[9]
Philip Y. Wai and Paul C. Kuo
Journal of Surgical Research, 2004, Volume 121, Number 2, Page 228
[10]
Carlos E. Marroquin, Laura Downey, Hongtao Guo, and Paul C. Kuo
Immunology Letters, 2004, Volume 95, Number 1, Page 109
[11]
Gisle Berge, Solveig Pettersen, Ida Grotterød, Ingrid J. Bettum, Kjetil Boye, and Gunhild M. Maelandsmo
International Journal of Cancer, 2011, Volume 129, Number 4, Page 780
[12]
Lusine Aghajanova, Carlos Simón, and José A Horcajadas
Expert Review of Obstetrics & Gynecology, 2008, Volume 3, Number 4, Page 487
[13]
Richard J. Warrington and Keith E. Lewis
Cancer Immunology, Immunotherapy, 2011, Volume 60, Number 2, Page 187
[14]
Devanshi Seth, Nympha B. D’Souza El-Guindy, Minoti Apte, Montserrat Mari, Steven Dooley, Manuela Neuman, Paul S. Haber, Gopal C. Kundu, Agus Darwanto, Willem J. de Villiers, A. Vonlaufen, Z. Xu, P. Phillips, S. Yang, D. Goldstein, R. M. Pirola, J. S. Wilson, Anna Moles, Anna Fernández, Anna Colell, Carmen García-Ruiz, José C. Fernández-Checa, Christoph Meyer, and Nadja M. Meindl-Beinker
Alcoholism: Clinical and Experimental Research, 2010, Volume 34, Number 1, Page 4
[16]
Philip Y. Wai and Paul C. Kuo
Cancer and Metastasis Reviews, 2008, Volume 27, Number 1, Page 103
[17]
Jo Caers, Ursula Gunthert, Hendrik Raeve, Els Van Valckenborgh, Eline Menu, Ivan Van Riet, Benjamin Van Camp, and Karin Vanderkerken
British Journal of Haematology, 2005, Volume 0, Number 0, Page 051220022257013
[18]
Youwen Zhou, Derek L. Dai, Magdalena Martinka, Mingwan Su, Yi Zhang, Eric I. Campos, Irene Dorocicz, Liren Tang, David Huntsman, Colleen Nelson, Vincent Ho, and Gang Li
Journal of Investigative Dermatology, 2005, Volume 124, Number 5, Page 1044
[19]
Takahiro Terashi, Shinichi Aishima, Kenichi Taguchi, Yoshiki Asayama, Keishi Sugimachi, Shuji Matsuura, Mitsuo Shimada, Shinichiro Maehara, Yoshihiko Maehara, and Masazumi Tsuneyoshi
Liver International, 2004, Volume 24, Number 1, Page 38
[20]
Adriano Angelucci, Claudio Festuccia, Giovanni Luca Gravina, Paola Muzi, Loriana Bonghi, Carlo Vicentini, and Mauro Bologna
The Prostate, 2004, Volume 59, Number 2, Page 157
[21]
Kwanchanit Tantivejkul, Linda M. Kalikin, and Kenneth J. Pienta
Journal of Cellular Biochemistry, 2004, Volume 91, Number 4, Page 706

Comments (0)

Please log in or register to comment.
Log in